SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-09-000860
Filing Date
2009-04-24
Accepted
2009-04-24 08:30:37
Documents
14
Period of Report
2009-06-12
Effectiveness Date
2009-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT regeneron_def14a.htm DEF 14A 583230
2 GRAPHIC regeneron_def14a1x1x1.jpg GRAPHIC 15615
3 GRAPHIC regeneron_def14a1x1x2.jpg GRAPHIC 6227
4 GRAPHIC regeneron_def14a1x3x1.jpg GRAPHIC 6900
5 GRAPHIC regeneron_def14a1x8x1.jpg GRAPHIC 8791
6 GRAPHIC regeneron_def14a1x8x2.jpg GRAPHIC 8767
7 GRAPHIC regeneron_def14a1x8x3.jpg GRAPHIC 8518
8 GRAPHIC regeneron_def14a2x1x1.jpg GRAPHIC 8855
9 GRAPHIC regeneron_def14a2x1x2.jpg GRAPHIC 9145
10 GRAPHIC regeneron_def14a2x1x3.jpg GRAPHIC 9605
11 GRAPHIC regeneron_def14a2x1x4.jpg GRAPHIC 9165
12 GRAPHIC regeneron_def14a2x2x1.jpg GRAPHIC 8585
13 GRAPHIC regeneron_def14a2x2x2.jpg GRAPHIC 8466
14 GRAPHIC regeneron_def14a2x2x3.jpg GRAPHIC 9137
  Complete submission text file 0001206774-09-000860.txt   748997
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19034 | Film No.: 09767987
SIC: 2834 Pharmaceutical Preparations